Chlamydia in Pregnancy and the Newborn Risk

Why is chlamydia screened for during pregnancy?

Sexually active women 24 and younger, and women 25 and older with risk factors, are recommended for chlamydia and gonorrhea screening under current guidance 1Ref 1US Preventive Services Task Force (2021).Chlamydia and Gonorrhea: Screening.Supports the 2021 USPSTF Grade B recommendation to screen for chlamydia and gonorrhea in sexually active women 24 and younger and in women 25 and older at increased risk, used to explain why chlamydia screening is folded into prenatal visits. — and pregnancy is exactly the kind of visit where that screening typically happens, since a first prenatal appointment already includes a broader sexual health panel. Being pregnant does not change whether someone falls into a recommended screening group; it just guarantees the visit where testing gets done.

Gonorrhea is screened for at the same time because it shares many of chlamydia's most frustrating qualities: it's common, curable, and just as capable of causing no symptoms at all 2Ref 2Centers for Disease Control and Prevention (2024).About Gonorrhea.Supports that gonorrhea is a common, curable bacterial STI that is often asymptomatic, used to explain why it is typically screened for alongside chlamydia at the same prenatal visit.. Chlamydia infection is frequently silent, showing up in a large share of the people who have it without a single symptom 3Ref 3Centers for Disease Control and Prevention (2024).About Chlamydia.Supports that chlamydia is a common, curable bacterial STI that is frequently asymptomatic ('silent'), can cause pelvic inflammatory disease and infertility if untreated, is treated with antibiotics, and can be transmitted to a newborn during delivery., which means pregnancy screening is often the only reason it gets caught at all. Waiting for symptoms is not a reliable strategy for chlamydia at any point, and it is an especially risky one to rely on this close to a delivery date.

The timing of that first prenatal panel matters too. Screening early in pregnancy leaves enough time to treat and confirm the infection has cleared well before delivery, rather than discovering it in the final weeks when there is less room to act. For anyone with ongoing risk factors after that first negative result, a second round of screening later in pregnancy is a reasonable conversation to have, since pregnancy itself does not pause exposure to a new infection.

What happens if it isn't caught before delivery — the newborn risk

Chlamydia does not cross the placenta the way some infections do; the risk to a newborn comes from contact during delivery itself, when a baby passes through a birth canal carrying an active infection 3Ref 3Centers for Disease Control and Prevention (2024).About Chlamydia.Supports that chlamydia is a common, curable bacterial STI that is frequently asymptomatic ('silent'), can cause pelvic inflammatory disease and infertility if untreated, is treated with antibiotics, and can be transmitted to a newborn during delivery.. That exposure can lead to an eye infection or pneumonia in the newborn in the weeks after birth, which is why untreated chlamydia at delivery is taken seriously even when the pregnancy itself has otherwise been uncomplicated.

That risk is also why treating chlamydia before delivery matters even when a pregnant person feels completely well. treating chlamydia early enough removes the exposure at the moment that actually matters — delivery — rather than trying to manage a newborn infection after the fact.

A cesarean delivery is not automatically the answer to an untreated infection either. Delivery method is a decision made with an obstetric clinician weighing the full picture, not a substitute for treating the infection itself beforehand, since the safest and most reliable path is still clearing the infection with time to spare before birth.

Is chlamydia treatable during pregnancy?

Yes. Chlamydia is treated with antibiotics 3Ref 3Centers for Disease Control and Prevention (2024).About Chlamydia.Supports that chlamydia is a common, curable bacterial STI that is frequently asymptomatic ('silent'), can cause pelvic inflammatory disease and infertility if untreated, is treated with antibiotics, and can be transmitted to a newborn during delivery., and a clinician chooses a pregnancy-appropriate option rather than assuming the same approach used outside pregnancy applies. Treatment is not something to delay until after delivery — the goal is to clear the infection well before birth, which is why the timing of the initial screening matters as much as the treatment itself.

Retesting after treatment is a standard part of the process during pregnancy, more so than it might be otherwise, since confirming the infection actually cleared before delivery is the entire point. A repeat test later in pregnancy is also common for anyone who remains at ongoing risk, since a new exposure after an earlier negative or treated result is always possible.

How chlamydia fits into the rest of prenatal STI screening

Chlamydia screening does not happen in isolation. The same prenatal visits that check for chlamydia and gonorrhea typically also screen for syphilis, HIV, and hepatitis 4Ref 4Centers for Disease Control and Prevention (2021).STI Screening Recommendations.Supports CDC's population-specific STI screening recommendations, including pregnancy screening for syphilis, HIV, and hepatitis, used to describe the bundled prenatal STI panel chlamydia screening is part of., which is why a single blood draw and swab at an early prenatal visit often does more work than it might seem to at the time.

Other infections carry their own version of a newborn-risk conversation. Congenital syphilis, for instance, can cause stillbirth or severe illness in an infant if untreated in the mother, and penicillin remains the only treatment proven to prevent it during pregnancy 5Ref 5Centers for Disease Control and Prevention (2024).About Congenital Syphilis.Supports that syphilis can pass to a fetus during pregnancy causing congenital syphilis, that it can cause stillbirth or severe illness in an infant, and that penicillin is the only treatment proven effective at preventing it during pregnancy, used as a comparison to chlamydia's own newborn-risk profile.. Trich in pregnancy and herpes in pregnancy raise similarly specific questions about timing and delivery planning, each with its own answer rather than a shared one — chlamydia's newborn risk is a delivery-contact issue, not identical to how syphilis or herpes cross to a baby.

The bigger picture: stis in pregnancy

Chlamydia is one piece of a broader prenatal screening conversation, not a standalone concern. For a fuller view of stis in pregnancy — what gets tested, when, and how the timing interacts with delivery planning — that broader picture is covered separately, since no single infection tells the whole story of a prenatal STI panel.

a chlamydia diagnosis during pregnancy is common, treatable, and, when caught and treated before delivery, generally resolves without lasting effect on the pregnancy or the newborn. The point of early screening is precisely to make that the most likely outcome, not to suggest that a diagnosis mid-pregnancy is somehow too late to matter.

Why treating it still matters for future fertility, not just this pregnancy

Chlamydia left untreated can cause pelvic inflammatory disease and, over time, infertility 3Ref 3Centers for Disease Control and Prevention (2024).About Chlamydia.Supports that chlamydia is a common, curable bacterial STI that is frequently asymptomatic ('silent'), can cause pelvic inflammatory disease and infertility if untreated, is treated with antibiotics, and can be transmitted to a newborn during delivery. — a risk that exists whether or not someone is currently pregnant. Being pregnant now does not undo that risk for the future; an infection that goes untreated through this pregnancy can still cause lasting reproductive tract effects afterward.

That is one more important reason treatment during pregnancy is not simply about protecting the current delivery alone. Clearing the infection now protects both the newborn's exposure at birth and the parent's longer-term reproductive health, which is why clinicians treat a prenatal chlamydia diagnosis as something to resolve promptly, with a confirmed retest, rather than something to revisit casually after the baby is born.